Cargando…
Current and future research efforts in oligometastatic non-small cell lung cancer—a systematic review
BACKGROUND: Major progresses in the systemic treatment of non-small cell lung cancer (NSCLC) were obtained during the last decade, including the use of immunotherapy and tyrosine kinase inhibitors (TKIs), with impressive results in terms of response and survival rates. Moreover, novel imaging and ra...
Autores principales: | Brandão, Mariana, Durieux, Valérie, Berghmans, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350078/ https://www.ncbi.nlm.nih.gov/pubmed/34430381 http://dx.doi.org/10.21037/tlcr-20-964 |
Ejemplares similares
-
Oligometastatic non-small cell lung cancer: from biology to clinical practice
por: Infante, Maurizio V., et al.
Publicado: (2021) -
Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021) -
Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer
por: Rashdan, Sawsan, et al.
Publicado: (2021) -
The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
por: Berzenji, Lawek, et al.
Publicado: (2021) -
Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)